Ginkgo Bioworks Holdings Inc [NYSE: DNA] price surged by 10.60 percent to reach at $0.08. The one-year DNA stock forecast points to a potential upside of 55.21. The average equity rating for DNA stock is currently 3.14, trading closer to a bullish pattern in the
Ginkgo Bioworks Holdings Inc [NYSE: DNA] stock went on a downward path that fall over -6.46% on Friday, amounting to a one-week price decrease of less than -14.37%. Over the last 12 months, DNA stock dropped by -34.48%. The one-year Ginkgo Bioworks Holdings Inc stock
Ginkgo Bioworks Holdings Inc [NYSE: DNA] traded at a low on Friday, posting a -3.81 loss after which it closed the day’ session at $1.01. The results of the trading session contributed to over 14046314 shares changing hands. Over the past one week, the price
Ginkgo Bioworks Holdings Inc [NYSE: DNA] gained 0.93% on the last trading session, reaching $1.08 price per share at the time. The company report on April 4, 2024 at 7:01 AM that Ginkgo Bioworks to Host 5th Annual Ferment Conference. Ginkgo Bioworks (NYSE: DNA), which
Ginkgo Bioworks Holdings Inc [NYSE: DNA] jumped around 0.06 points on Thursday, while shares priced at $1.16 at the close of the session, up 5.45%. The company report on March 28, 2024 at 7:02 AM that Ginkgo Bioworks Awarded DARPA Funding to Produce Novel Proteins
Ginkgo Bioworks Holdings Inc [NYSE: DNA] gained 1.87% or 0.02 points to close at $1.09 with a heavy trading volume of 11272960 shares. The company report on March 12, 2024 at 7:01 AM that CDC Traveler-based Genomic Surveillance Program to Expand to Two New US
Ginkgo Bioworks Holdings Inc [NYSE: DNA] traded at a low on Friday, posting a -6.14 loss after which it closed the day’ session at $1.07. The company report on March 12, 2024 at 7:01 AM that CDC Traveler-based Genomic Surveillance Program to Expand to Two
Ginkgo Bioworks Holdings Inc [NYSE: DNA] closed the trading session at $1.08. The company report on March 12, 2024 at 7:01 AM that CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago. The TGS program, a leading
Ginkgo Bioworks Holdings Inc [NYSE: DNA] price surged by 1.67 percent to reach at $0.02. The company report on February 29, 2024 at 5:01 PM that Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results. $251 million of Total revenue in 2023. $139
Ginkgo Bioworks Holdings Inc [NYSE: DNA] slipped around -0.23 points on Friday, while shares priced at $1.29 at the close of the session, down -15.13%. Compared to the average trading volume of 21.96M shares, DNA reached a trading volume of 60095536 in the most recent
© 2024, Powered by Smart TechOne
